Atıf İçin Kopyala
Giugliano R. P., Ruff C. T., Rost N. S., Silverman S., Wiviott S. D., Lowe C., ...Daha Fazla
STROKE, cilt.45, sa.8, ss.2372-2378, 2014 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
45
Sayı:
8
-
Basım Tarihi:
2014
-
Doi Numarası:
10.1161/strokeaha.114.006025
-
Dergi Adı:
STROKE
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.2372-2378
-
Anahtar Kelimeler:
anticoagulant, atrial fibrillation, cerebral hemorrhage, stroke, ORAL ANTICOAGULANTS, THERAPY, STROKE, METAANALYSIS, INHIBITION, PREVENTION, DABIGATRAN, INTENSITY
-
Gazi Üniversitesi Adresli:
Evet
Özet
Background and Purpose-The once-daily oral factor Xa inhibitor, edoxaban, is as effective as warfarin in preventing stroke and systemic embolism while decreasing bleeding in a phase III trial of patients with atrial fibrillation at moderate-high stroke risk. Limited data regarding cerebrovascular events with edoxaban were reported previously.